Last reviewed · How we verify
NCT05389358
Addressing Intimate Partner Violence, Mental Health, and HIV in Antenatal Care
NA trial testing Asiphephe health worker training in Partner Abuse in 80 participants. Status unknown.
31 March 2024
Quick facts
| Lead sponsor | University of Witwatersrand, South Africa |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 80 |
| Start date | 26 April 2022 |
| Primary completion | 31 March 2024 |
| Estimated completion | 30 June 2024 |
| Sites | 2 locations across South Africa |
Drugs / interventions tested
- Asiphephe health worker training
- Asiphephe therapeutic sessions
- IPV assessment
- Referral for IPV or Mental Health
Conditions studied
- Partner Abuse — all drugs for Partner Abuse →
- Depression — all drugs for Depression →
- Adherence, Medication — all drugs for Adherence, Medication →
Sponsor
University of Witwatersrand, South Africa
Who can join
18 and older, female only, with Partner Abuse or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This quasi-experimental feasibility study recruit n=40 participants from each of two public antenatal clinics in Johannesburg, South Africa. Using the Bowen et al. approach, key feasibility study questions will be those around acceptability, implementation, and promising effects on intermediate variable. While this pilot trial is not powered to determine efficacy, it can help establish whether intervention targets the appropriate intermediate mechanisms (i.e. primary endpoints of IPV exposure and depressive symptoms) and moves intended outcomes in the right direction (i.e. towards better adherence as measured by self-reported adherence).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05389358
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Witwatersrand, South Africa trials
Trials by the same sponsor.
- NCT06821152 — Functional Performance and Acceptability Evaluation of the Miss Liberty Female Condom Compared to the FC2 Female Condom · NA · completed
- NCT06955728 — A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respirato · Phase 4 · not yet recruiting
- NCT06485154 — Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial · Phase 4 · active not recruiting
- NCT06138600 — Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Car · Phase 3 · active not recruiting
- NCT05846503 — iHEART-SA Intervention Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05389358 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Witwatersrand, South Africa
- Last refreshed: 25 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05389358.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing